(Q68245521)

English

Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal women

scientific article published on 01 April 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal women (English)

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Hormone Replacement Therapy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

author name string

C. Boschetti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649497

21 October 2022

M. Cortellaro

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649497

21 October 2022

T. Nencioni

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649497

21 October 2022

V. Bertolli

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649497

21 October 2022

A. Della Volpe

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649497

21 October 2022

C. Zanussi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649497

21 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1649497

21 October 2022

publication date

1 April 1991

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:004938489190663H?httpAccept=text/xml

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

https://api.elsevier.com/content/article/PII:004938489190663H?httpAccept=text/plain

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Thrombosis Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

62

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Estrogen replacement therapy.

1

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

At III content and antithrombin in activity in oestrogen-progestogen and progestogen-only treated women

2

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Thromboembolic disease and the steroidal content of oral contraceptives

3

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

A prospective study of postmenopausal estrogen therapy and coronary heart disease

6

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

7

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

The fibrinogen-dependent pathway of platelet aggregation

11

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Fibrin(ogen), platelets and a new theory of atherogenesis

12

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations

14

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

The concentration of antihemophilic globulin (AHG) in patients with coronary artery disease

15

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Atherosclerosis and hemostasis

16

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Oral contraceptives, blood clotting and thrombosis

17

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Clinical relevance of antithrombin III.

20

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Antithrombin III and heparin

21

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Antithrombin III and procoagulant activity: sex differences and effects of the menopause

22

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Biologic effects of transdermal estradiol

23

1 reference

10.1016/0049-3848(91)90663-H

https://api.crossref.org/works/10.1016/0049-3848(91)90663-H

21 October 2022

Identifiers

10.1016/0049-3848(91)90663-H

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1649497%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68245521&oldid=2149752895"